Elanco Animal Health (ELAN) Income towards Parent Company (2017 - 2026)

Elanco Animal Health has reported Income towards Parent Company for 10 years, with the latest figure at $57.0 million in Q1 2026.

• Quarterly Income towards Parent Company fell 14.93% year-over-year to $57.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.0 million (down 164.88% YoY) and the FY2025 annual result came in at -$232.0 million, down 168.64% from the prior year.
• Income towards Parent Company advanced to $57.0 million in Q1 2026 per ELAN's latest filing, from -$276.0 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $364.0 million in Q3 2024 and troughed at -$1.1 billion in Q3 2023.
• A 5-year average of -$67.4 million and a median of -$10.0 million in 2022 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company jumped 179.69% in 2022, then sank 3350.0% in 2025.
• Over 5 years, Income towards Parent Company stood at -$54.0 million in 2022, then slumped by 161.11% to -$141.0 million in 2023, then soared by 94.33% to -$8.0 million in 2024, then tumbled by 3350.0% to -$276.0 million in 2025, then jumped by 120.65% to $57.0 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $57.0 million, -$276.0 million, and -$34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.